Home > Healthcare > Medical Devices > Medical Supplies > Amniocentesis Needle Market

Amniocentesis Needle Market Size

Report ID: GMI8186
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Amniocentesis Needle Market Size

The global amniocentesis needle market size was valued at USD 176.7 million in 2023 and is estimated to grow at 4.9% CAGR from 2024 to 2032. An amniocentesis needle is a specialized medical instrument utilized in amniocentesis, a procedure that extracts amniotic fluid from the sac surrounding a developing fetus during pregnancy.

To get key market trends

Download Free Sample

The rising prevalence of chronic diseases in expectant mothers significantly propels the amniocentesis needle market. Conditions like diabetes, hypertension, autoimmune disorders, and specific genetic issues can negatively impact pregnancy outcomes and elevate the risk of fetal complications. According to the National Library of Medicine, gestational diabetes mellitus had a global prevalence of 14.7% in 2022. When combined with advanced maternal age, gestational diabetes often prompts recommendations for amniocentesis to evaluate fetal chromosomes, boosting the demand for amniocentesis needles in clinical settings.

Amniocentesis Needle Market Report Attributes
Report Attribute	Details
Base Year:	2023
Amniocentesis Needle Market Size in 2023:	USD 176.7 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	4.9%
2032 Value Projection:	USD 272.6 Million
Historical Data for:	2021 - 2023
No. of Pages:	135
Tables, Charts & Figures:	100
Segments covered:	Product Type, Procedure, End Use, and Region
Growth Drivers:	Increasing number of amniocentesis procedures Growing burden of congenital disorders Rising prevalence of chronic diseases among expectant mothers Technological advancements in amniocentesis needles
Pitfalls & Challenges:	Availability of alternative methods Dearth of skilled professionals

Learn more about the key segments shaping this market

Download Free Sample

Additionally, the growing incidence of congenital disorders and the uptick in amniocentesis procedures bolster the market's revenue. Technological advancements in the design and functionality of amniocentesis needles significantly enhance their efficacy and safety. Together, these factors fuel the demand for amniocentesis procedures, enabling early diagnosis and better management of fetal health concerns, thus propelling market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of amniocentesis needle reached USD 176.7 million in 2023 and is set to grow at a 4.9% CAGR from 2024 to 2032, driven by the increasing number of amniocentesis procedures.

The amniocentesis procedures segment held a 33.1% market share in 2023, as it serves as a crucial diagnostic tool for identifying genetic anomalies.

The U.S. market was valued at USD 62.6 million in 2023, led by a higher prevalence of congenital disorders.

Key players in the industry include Becton, Dickinson and Company, Biopsybell, Cardinal Health, Eurosurgical, Laboratoire CCD, M.D.L, McKesson Corporation, Medax, Medline Industries, Moller Medical, RI.MOS, and Roko.